ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 3,060.00
+30.00 (0.99%)
At close: Aug 28, 2025
ADBiotech Revenue
ADBiotech had revenue of 3.45B KRW in the quarter ending March 31, 2025, with 17.88% growth. This brings the company's revenue in the last twelve months to 11.66B, up 12.56% year-over-year. In the year 2024, ADBiotech had annual revenue of 11.14B with 6.34% growth.
Revenue (ttm)
11.66B
Revenue Growth
+12.56%
P/S Ratio
3.31
Revenue / Employee
197.63M
Employees
59
Market Cap
38.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.14B | 664.30M | 6.34% |
| Dec 31, 2023 | 10.47B | -159.63M | -1.50% |
| Dec 31, 2022 | 10.63B | -1.21B | -10.21% |
| Dec 31, 2021 | 11.84B | 2.02B | 20.63% |
| Dec 31, 2020 | 9.82B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hyundai Motor Company | 182.25T |
| Hanwha Aerospace | 19.25T |
| HD Hyundai Heavy Industries | 15.58T |
| Doosan Enerbility | 16.30T |